Abstract:[Introduction] The majority of patients with pancreatic cancer are inoperable at the time of diagnosis and even those cases with successful tumor resection for early-stage tumors frequently had second tumors within the remaining pancreas shortly after the surgery, contributing to a poor clinical outcome. Additionally, synchronous multiple pancreatic cancers have been frequently documented. One of the long-standing issues about such synchronous and/or metachronous multiple pancreatic cancers is their clonal origins. This study is designed to elucidate the origin of multiple pancreatic cancers through an unbiased detection of somatic mutations in primary and metachronous cancers, along with adjacent precursor lesions. [Methods] Serially obtained formalin-fixed paraffin-embedded surgical specimens from 20 patients who had undergone curative surgery for an early-stage pancreatic cancer were subjected to laser microdissection for the enrichment of tumor and precancerous lesions, from which DNA was extracted and analyzed for somatic mutations using whole-exome sequencing (WES) with matched normal DNA. The investigation into the shared and private mutations across different samples aimed to unveil the clonal evolution history of these lesions. [Results] We analyzed 20 patients with multiple pancreatic cancers of 2 metachronous and synchronous, 16 metachronous, and 2 synchronous tumors. In metachronous cases, all patients exhibited margin-negative pathology for the primary cancer, with a median interval of 38.9 months (ranging from 7 to 85 months) between the initial and second surgery. In addition, a total of 20 pancreatic intraepithelial neoplasia (PanIN) from 5 of these cases were analyzed. We identified a median of 66 (range: 31-232) and 20 (14-42) somatic mutations in cancer and PanIN lesions, respectively. None of the patients have known pathogenic germline variants. All samples had one or more driver mutations. In most cases (N=19), sharing many somatic mutations, multiple tumors had a common clonal origin. In another synchronous case, the synchronous tumors shared only one mutation, suggesting that they were clonally independent tumors. By contrast, none of the mutations other than hotspot KRAS mutations were shared between precursor and cancer lesions. While multiple independent clones were observed in precancerous lesions, most of multiple cancers originated from a common ancestor. Moreover, negative pathology of the margins at the initial surgery suggested that those multiple lesions arose from distant dissemination or metastasis, rather than contiguous, intraductal invasion. [Conclusions] In conclusion, our study suggests that even in early pancreatic cancer, dissemination within the pancreas may occur, contributing to the development of synchronous and metachronous cancers. Citation Format: Tomonori Hirano, Nobuyuki Kakiuchi, Yasuhide Takeuchi, Takayuki Anazawa, Kazuyuki Nagai, Toshihiko Masui, Sachiko Minamiguchi, Hironori Haga, Takeshi Tanaka, Atsuhiro Masuda, Yuzo Kodama, Norimitsu Uza, Hiroshi Seno, Satoru Miyano, Hiroko Tanaka, Seishi Ogawa. Origin of synchronous or metachronous multiple pancreatic cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5659.

Identifying The Clonal Origin Of Synchronous Multifocal Tumors In The Hepatobiliary And Pancreatic System Using Multi-Omic Platforms

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

A Naive Bayes Algorithm for Tissue Origin Diagnosis (Tod-Bayes) of Synchronous Multifocal Tumors in the Hepatobiliary and Pancreatic System

Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.

Abstract 5659: Origin of synchronous or metachronous multiple pancreatic cancers

IDDF2018-ABS-0097 Genomic heterogeneity and clonal evolution of multifocal hepatocellular carcinoma

Comprehensive Genomic Profiling Aids in Understanding the Lesion Origins of a Patient with Six Synchronous Invasive Lung Adenocarcinomas: a Case Study

Molecular profiling of Chinese patients with advanced hepatocellular carcinoma using circulating tumor DNA.

Identification of Portal Vein Tumor Thrombus with an Independent Clonal Origin in Hepatocellular Carcinoma Via Multi-Omics Data Analysis

Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma

Abstract 3394: Diagnosis of Intrahepatic Metastasis (IM) and Multi-Entric (MC) Carcinogenesis by Novel Mutational Signature in Patients with Multiple and Recurrent Hepatocellular Carcinomas

Integrative Clonal Evolution Analysis on SNV and CNV Levels in Multifocal Breast Cancer

A Comparison Of Isolated Circulating Tumor Cells And Tissue Biopsies Using Whole-Genome Sequencing In Prostate Cancer

Clonality analysis of synchronous gastroesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.

Real-world Fusion Landscape in Advanced Chinese Pancreatic Cancer Using Next Generation Sequecing: A Multicenter Study

Genomic and Transcriptional Heterogeneity of Multifocal Hepatocellular Carcinoma.

Cross Analysis of Genomic-Pathologic Features on Multiple Primary Hepatocellular Carcinoma

Progress in the identification of clonal origin and treatment of multifocal hepatocellular carcinoma

Inferring the Progression of Multifocal Liver Cancer from Spatial and Temporal Genomic Heterogeneity

Abstract 208: Multi-omics Analysis in Primary Cell Cultures Reveals the Genomic Basis of Phenotypic Diversity Within Tumors

Pan-cancer Transcriptome Analysis Reveals a Gene Expression Signature for the Identification of Tumor Tissue Origin.